CTIX News 08/19/2014 22:32:01 $CTIX Good luck and GOD

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
CTIX News 08/19/2014 22:32:01 $CTIX
Good luck and GOD bless,
Go CTIX!
I agree with George, Kevetrin will be a game changer but it is several years out.

many combo trials await and lets not forget Bologna

Oh, by the way, why hasn't that trial started yet ?

Maybe Leo will update us at R and R in NYC

20 days left till conference updates

CTIX Stock Message Board http://investorshangout.com/Cellceutix-Corpor...TIX-87375/

Yawwwn. Not again. This horse is dead. George did you miss a chance to average down. Come on let's move along. It's been a good day for Pete's sake. Can we give it a days rest
As I have said before do not expect miracles for Kevetrin.

I do however that Kevetrin will be a blockbuster drug as an diction to standard chemotherapy and/or radiation therapy.

I hope that EllaRuth is right, but I doubt it.

Good luck and GOD bless,

George
Miles, hang in there. Charts nor anyone can tell you when a stock will be quadruple swing term then more. Sound familiar? Long over 100k on that one and done for the year? Not by a long shot. In fact, long again in that one and you know the share count. The secret is the best stock now hopefully at the right time. And if the timing is off, you're best stock now will still save in the end. Don't allow the short term TA mumbo jumbo to distort. Use the reading I did to temp sell like on our other one, it's the best there is and I posted it real time. No worries my friend and Shalom......................
Patience.......the art of concealing ones impatience. Our patience will be rewarded in time. We have breathed this $2 air before, but it smells sweeter this time, knowing good news on all fronts and trial escalation is eminent. SP dilution by Aspire selling is disconcerting, yes....but is still necessary. Three solid days consecutively. Yeah baby, I'll take that. Go CTIX and Go Gamecocks!!!! Kickoff is only 8 days away.
Well then, I suppose you must be one of the posters who "carefully read the PRs, know the industry or the science, show the patience of an experienced investor, and disregard those irrelevant posts."

Otherwise...?

For what it's worth, there are a number of posters who don't have access to real time bid and ask and appreciate knowing what's going on when things are hot.
Go Miles! I agree the big wall at $2.00 seemed so desperate and obvious there must be a reason beyond traders seeing the RSI top out. Ridiculous. Someone got caught short and is trying to cap it. This started over a week ago.

Go CTIX!
I have to admit, I ignore "TA" posts. Same with posts about the bid/ask, guessing the close, complaining about "greedy MM's trying to steal shares", etc. The only useful thing about those posts is they help me identify the posters whose opinions I shouldn't put as much weight on.

The folks who carefully read the PRs, know the industry or the science, show the patience of an experienced investor, and disregard those irrelevant posts, they're the ones worth reading and are why I'm here.
Thank you sir, the rat in my brain that was doing all the gnawing has been euthanized. I will no longer have to wake up at 4am worrying about P.
Checking in ! I told you GREAT things happen on my Birthday ! Life and GOD is GOOD and LEO is GOOD as well ! And Dr. Menon and his Chemistry Knowledge and TINKERING is COMPELLING ! Keep the FAITH Pals ! BTW....I took care of that " Twinkle " and had a wonderful day ! : )

GO CTIX !
Jok, I had same question on Prurisol/abacavir a few weeks ago and got helpful answers, search my posts
I know that what i see in the rat slides, if it works that well in humans, it will blow the roof off of psoriasis treatment.


Thanks
Can someone kindly explain to me the difference between prurisol and Ziagen (Abacavir) ? If prurisol converts to Abacavir once it enters the body why isn't Ziagen used to treat Psorisis. I know that Ziagen is used to treat HIV. Could prurisol be used for the same? This has been gnawing at my brain for a while.


Thanks JOK
I hope you are right.
I like TA as much as the next guy...

NR is my favorite chartist on ANY board and I respect him immensely, which is why the following is so difficult to say:

You are wrong. How do I know? Because I just typed that.

Witness the 60k+ wall thrown up at $2.00.
Desperation is a stinky cologne.
They can't keep a lid on this. Not at this pace.
Some person or persons is more than happy to gobble at 2.00 ALL day long. There is a finite number of shares at $2 and it seems to be fairly thin after that.
Yes, yes, I know what RSI says. Have you never witnessed a sustained move with RSI pegged? I have.
We've been coiled for so long, with so many catalysts brewing, now coming to fruition, that at some point, charts just don't explain it any longer.
Did the charts predict six figure volume three trading days in a row, and now approaching seven figs?

I think we continue running with any pullbacks being very minor.
Another high volume day tomorrow with a solid push and hold over $2 and we will never see sub $2 again.

I love your posts and charts and will continue to do so.
This is simply my feelings on the matter and more or less mean nothing. I will toot my own horn a bit and point out that I did call for $2 this week while most were saying one or two weeks.

Ready to suit up.
Let me have it.
That's right around the area I was thinking too BigK. But that's just the beginning. Around $300 - $650m per quarter sales is a good slice of the pie imo. I'm not one to get ahead of myself though. But a $4 - $8 pps market cap somewhere during phase 2/3 isn't out of the question. Then with something solid comes the uplisting.

Quote:
Considering market, B-ABSSSI license alone is worth $350 million to $500 million ($700 million is within range but a little on the high side IMO), including $35 million to $100 million upfront.

We now have 6 other 1/2 billion to billion dollar indications/formulations for B:
Brilacidin-OM
Brilacidin-Ocular
Brilacidin-Otic
Gram Negative Bacteria
Candidiasis
Diabetic Foot Infections/Ulcers

That's a lot of Phase 2/3 trials to move, so it would be very nice to license ABSSSI and pay for everything else, including K and P.


Just my own WAG.



I don't think it is realistic to expect that...I hope you are right, but I can't see it, not even down the road a ways.
$700 million would be my estimate for B, period, all indications, given a favorable p2b. I don't think that is too low at this point. Others do, and that is okay. After p3 and the trials for the other indications, 2 billion or so. So is it worth the wait and the additional dilution? What is the risk of B not doing so well v. other indications?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Getlabs Brings GI Test Kits to Your Doorstep

Updated Category News Views 92

Home Testing: A Game Changer for GI Patients Imagine dragging yourself out of bed, managing gut issues, only to face a grueling trip to a lab. It's the last thing a patient with GI symptoms wants. Enter Getlabs and Genova Diagnostics with a welcome shift: a partnership that promises to bring the lab to your doorstep—literally. The Partnership Expansion Getlabs, the...

Continue Reading
LUNGevity's Bold $1M Bet on Lung Cancer Research

Updated Category News Views 24

Investing in the Future of Lung Cancer Research Damn, you don't see this kind of commitment every day! LUNGevity Foundation is dropping over a million bucks on the table to swell the ranks of lung cancer researchers. They're not just tossing dollars at established players; they're betting on fresh minds to shake things up in this critical field. Tackling lung cancer isn't...

Continue Reading
Ad Council Expands Board, Taps Meta Exec as Vice Chair

Updated Category News Views 203

An Unexpected Shuffle at the Ad Council Alright, folks, let's talk shop about the recent shake-up in the nonprofit realm. The Ad Council, which has been around longer than some of the giants controlling today's marketing landscapes, just plumped up its Board of Directors with 23 new heavy-hitters. We're talking about leaders from every nook and cranny of the...

Continue Reading
Radius Global Rebrands to Unite Infrastructure Investments

Updated Category News Views 43

Changing Gears to Navigate Global Connectivity Alright, buckle up because Radius Global Infrastructure, Inc. is making a move that’ll reshape how they play the digital infrastructure game. As of October 28, 2026, they’ve wrapped APWireless into their fold, waving goodbye to separate identities and hello to a unified brand. If you’ve got a finger in the tech pie,...

Continue Reading
Group 1 Automotive Q3 2026: Profits Soar, Revenues Dip

Updated Category News Views 34

Profits Up, Revenues Down Here's a tale for the books—Group 1 Automotive reports their third quarter results of 2026 and it's a bit like swapping a thunderstorm for a hurricane. Net income from continuing operations stomped on last year's figures, clocking in at a hefty $102.9 million compared to a skimpy $13.1 million. But don't let that fool you, their total revenues...

Continue Reading
Beta Bionics Faces Securities Fraud Class Action Challenges

Updated Category News Views 25

The Unexpected Slide of Beta Bionics So your wallet took a bruising with this Beta Bionics deal, eh? It’s another one of those wild tales from the stock jungle where everyone watching the NASDAQ:BBNX action got clipped when reality didn't match the company chest-thumping. Glancy Prongay Wolke & Rotter LLP just laid it out—ripping the Band-Aid off what Beta Bionics...

Continue Reading
Jamaica's Tourism Rebounds Post-Hurricane Challenges

Updated Category News Views 103

Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...

Continue Reading
Digimon Card Game Ventures into Digital Realms

Updated Category News Views 121

A Bold Leap for the Digimon Card Game Folks, if you've been tapping your foot waiting for Digimon to fire up a serious digital game, well, here's your moment. BANDAI CO., LTD. is rolling the dice as they launch pre-registration for DIGIMON ALYSION, a digital twist on the classic card game, across 49 countries. It's not just a game; it's a reimagining. They're not just...

Continue Reading
White House Photographer Reveals Unseen Historic Moments

Updated Category News Views 16

You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...

Continue Reading
FirstEnergy's New Tech to Bolster Pennsylvania Grid

Updated Category News Views 40

Electricity Demand Spurs Grid Innovation The winds of change are blowing across Pennsylvania's power grid. FirstEnergy Transmission's (NYSE:FE) subsidiary, Keystone Appalachian Transmission Company (KATCo), is diving into a significant federally funded project to reinforce grid reliability. With electricity demand on an upward trajectory, Pennsylvania and beyond need...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Why Woori Bank Stands Out as a Dividend Gem

Updated Category News Views 75

Why Investors Look for Dividend Stocks Plenty of investors chase growth across stocks, bonds, ETFs—you name it. But if you’re focused on income, the goal shifts: you want steady cash coming in from investments you can buy and sell without much friction. That cash can come from interest on bonds, dividends from stocks, and other income-paying assets. A dividend is...

Continue Reading
Lightbeam Health Triumphs Again as KLAS Champion for RPM

Updated Category News Views 144

Lightbeam Health Solutions Achieves Prestigious Award Lightbeam Health Solutions, recognized nationwide for its leadership in population health enablement technology, has once again demonstrated its commitment to excellence by winning the Best in KLAS award for Remote Patient Monitoring (RPM). This accolade comes with an impressive satisfaction score of 93.6 out of 100...

Continue Reading
Exploring the Best US Online Casinos for Real Money Players

Updated Category News Views 112

The Rise of Online Casinos: A Gamblers’ Paradise The world of online casinos has undergone a transformation, especially with the recent developments in 2025. Why settle for less when the best real money online casinos are just a click away? These establishments not only offer same-day payouts but have also introduced exciting features that enhance the gaming experience...

Continue Reading
Innovative Investment Fuels Growth in Mental Health Services

Updated Category News Views 331

Strategic Investment to Transform Mental Health Services Care Solace, a leading provider of mental health care coordination services tailored for K-12 schools and municipalities, has announced a transformative partnership with Lemnis, a philanthropic venture focused on enhancing educational experiences for all learners. This collaboration marks a significant moment for...

Continue Reading
Leading Figures Exit Activist Role in Major Pharmaceutical Firm

Updated Category News Views 93

Key Management Decisions Impacting Activist Campaign In a significant development, former Pfizer Inc (NYSE: PFE) CEO Ian Read and former CFO Frank D’Amelio have announced their decision to step back from the activist campaign led by Starboard Value. This unexpected move has raised questions about the future direction of the campaign and its impact on Pfizer's corporate...

Continue Reading